Targeted therapy in Liv Hospital Vadistanbul

Targeted therapy with bispecific antibodies is available at Liv Hospital Vadistanbul in Istanbul, Turkey. The treatment may cost around 43,820 EUR for three cycles, including hospitalization and medications. This advanced approach uses antibodies that bind two targets simultaneously for enhanced effectiveness against cancer cells.

Treatment Details

The therapy involves 21 nights of hospitalization per three-week cycle. Patients receive intensive monitoring throughout each treatment phase. The hospital collaborates with Boston Children's Hospital for complex pediatric cases.

What's Included

• Hematology consultation (170 EUR)
• Chemotherapy planning/administration (1,450 EUR)
• Targeted drug (3 mg vials): 27,500 EUR
• 21 nights hospitalization per cycle
• Free airport transfers
• Free interpreter services

The treatment follows a step-up approach. Doctors first administer targeted therapy. If sufficient remission occurs, they may recommend CAR-T cell therapy next. Patients undergo bone marrow biopsies after initial cycles to assess progress.

Payment is required before or during the first appointment. The clinic accepts credit cards, money orders, and bank transfers. Patients considering this treatment can request more details about the protocol and expected outcomes.